Anneloes E. Bohte

Anneloes E. Bohte

Auto-generated profile, based on publicly available information

Anneloes E. Bohte

Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2010 in European Radiology
Verified
Journal Article
Open access
PDF file
ABAnneloes E. Bohte
Anneloes E. Bohte
JWJochem R. van Werven
Jochem R. van Werven
SBShandra Bipat
Shandra Bipat
JSJaap Stoker
Jaap Stoker
Objective To meta-analyse the diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis. Methods From a comprehensive literature search in MEDLINE, EMBASE, CINAHL and Cochrane (up to November 2009), articles were selected that investigated the diagnostic performance imaging techniques for evaluating hepatic steatosis with histopathology as the reference standard. Cut-off values for the presence of steatosis on liver biopsy were subdivided into four groups: (1) >0, >2 and >5% steatosis; (2) >10, >15 and >20%; (3) >25, >30 and >33%; (4) >50, >60 and >66%. Per group, summary estimates for sensitivity and specificity were calculated. The natural-logarithm of the diagnostic odds ratio (lnDOR) was used as a single indicator of test performance. Results 46 articles were included. Mean sensitivity estimates for subgroups were 73.3–90.5% (US), 46.1–72.0% (CT), 82.0–97.4% (MRI) and 72.7–88.5% (1H-MRS). Mean specificity ranges were 69.6–85.2% (US), 88.1–94.6% (CT), 76.1–95.3% (MRI) and 92.0–95.7% (1H-MRS). Overall performance (lnDOR) of MRI and 1H-MRS was better than that for US and CT for all subgroups, with significant differences in groups 1 and 2. Conclusion MRI and 1H-MRS can be considered techniques of choice for accurate evaluation of hepatic steatosis.

25 October 2013 in European Radiology
Verified
Journal Article
Closed access
PDF file
ABAnneloes E. Bohte
Anneloes E. Bohte
ANAnnikki de Niet
Annikki de Niet
LJLouis Jansen
Louis Jansen
SBShandra Bipat
Shandra Bipat
ANAart J. Nederveen
Aart J. Nederveen
JSJaap Stoker
Jaap Stoker

1 January 2012 in Radiology
Verified
Journal Article
Closed access
ABAnneloes E. Bohte
Anneloes E. Bohte
BKBart G. P. Koot
Bart G. P. Koot
OBOlga H. van der Baan-Slootweg
Olga H. van der Baan-Slootweg
TRTammo H. Pels Rijcken
Tammo H. Pels Rijcken
JWJochem R. van Werven
Jochem R. van Werven
JSJaap Stoker
Jaap Stoker
To evaluate the diagnostic accuracy of ultrasonography (US) for the assessment of hepatic steatosis in severely obese adolescents, with proton magnetic resonance (MR) spectroscopy as the reference standard, and to provide insight on the influence of prevalence on predictive values by calculating positive and negative posttest probabilities. This prospective study was institutional review board approved. All participants, and/or their legal representatives, gave written informed consent. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the overall presence of steatosis and for the presence of substantial (moderate to severe) steatosis. Positive and negative posttest probabilities were calculated and plotted against prevalence. A total of 104 children (47 male, 57 female) were prospectively included. Mean age was 14.5 years (range, 8.3-18.9 years) and mean age-adjusted standard deviation body mass index (BMI) score (BMI z score) was 3.3 (range, 2.6-4.1). The overall prevalence of hepatic steatosis was 46.2% (48 of 104). Sensitivity of US was 85.4% (41 of 48), specificity was 55.4% (31 of 56), PPV was 62.1% (41 of 66), and NPV was 81.6% (31 of 38). The prevalence of substantial steatosis was 15.4% (16 of 104), with US sensitivity of 75.0% (12 of 16) and specificity of 87.5% (77 of 88). PPV was 52.2% (12 of 23) and NPV was 95.1% (77 of 81). Plotting of posttest probabilities against prevalence for both disease degrees demonstrated how disease prevalence influences US accuracy. Positive US results in severely obese adolescents cannot be used to accurately predict the presence and severity of hepatic steatosis, and additional imaging is required. Negative US results exclude the presence of substantial steatosis with acceptable accuracy. Steatosis prevalence differs among specific populations, strongly influencing posttest probabilities.

30 May 2018 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
ABA.E. Bohte
A.E. Bohte
JNJ.L. Nelissen
J.L. Nelissen
JRJ.H. Runge
J.H. Runge
OHO. Holub
O. Holub
SLS.A. Lambert
S.A. Lambert
RSR. Sinkus
R. Sinkus

27 February 2023 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
IVIsabelle S.A. de Vries
Isabelle S.A. de Vries
Roelof van EwijkRoelof van Ewijk
Roelof van Ewijk
LALaura M E Adriaansen
Laura M E Adriaansen
ABAnneloes E Bohte
Anneloes E Bohte
ABArthur Johannes Anthonius Theodorus Braat
Arthur Johannes Anthonius Theodorus Braat
RRRick R. van Rijn
Rick R. van Rijn
Rhabdomyosarcoma, although rare, is the most frequent soft tissue sarcoma in children and adolescents. It can present as a mass at nearly any site in the body, with most common presentations in the head and neck, genitourinary tract and extremities. The optimal diagnostic approach and management of rhabdomyosarcoma require a multidisciplinary team with multimodal treatment, including chemotherapy and local therapy. Survival has improved over the last decades; however, further improvement in management is essential with current 5-year overall survival ranging from 35% to 100%, depending on disease and patient characteristics. In the full patient journey, from diagnosis, staging, management to follow-up after therapy, the paediatric radiologist and nuclear physician are essential members of the multidisciplinary team. Recently, guidelines of the European paediatric Soft tissue sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology (ESPR), in an ongoing collaboration with the International Soft-Tissue Sarcoma Database Consortium, provided guidance for high-quality imaging. In this educational paper, given as a lecture during the 2022 postgraduate ESPR course, the multi-disciplinary team of our national paediatric oncology centre presents the journey of two patients with rhabdomyosarcoma and discusses the impact on and considerations for the clinical (paediatric) radiologist and nuclear physician. The key learning points of the guidelines and their implementation in clinical practice are highlighted and up-to-date insights provided for all aspects from clinical suspicion of rhabdomyosarcoma and its differential diagnosis, to biopsy, staging, risk stratification, treatment response assessment and follow-up.

3 July 2020 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
TPThomas Peros
Thomas Peros
JSJoost van Schuppen
Joost van Schuppen
ABAnneloes Bohte
Anneloes Bohte
CHCaspar Hodiamont
Caspar Hodiamont
EAEleonora Aronica
Eleonora Aronica
THTimo de Haan
Timo de Haan
Central nervous system (CNS) infections are potentially life threatening in neonates and can lead to the ill-defined diagnosis of ventriculitis. With this study we aimed to explore and describe ventriculitis regarding clinical, microbiological and ultrasonographic characteristics. We performed a retrospective cohort study including all neonates with a culture-proven CNS infection admitted to our tertiary NICU over a 12-year period (2004–2016). For each case clinical data was gathered, and three timed cranial ultrasounds were anonymized and retrospectively reviewed and assessed for signs of ventriculitis. Forty-five patients were included with 9 (20%) diagnosed with ventriculitis. Mortality in both ventriculitis and non-ventriculitis cases was one-third. Patients with pre-existing conditions as post-haemorrhagic hydrocephalus are at risk of developing ventriculitis. Most common pathogens were gram negative bacteria (68.9%). Ultrasonographic signs of ventriculitis developed over time, and interrater agreement was substantial.Conclusion: Neonatal ventriculitis is a serious entity in the continuum of meningitis. Early and correct diagnoses of ventriculitis are both important because of possible persisting or newly developing hydrocephalus or seizures. Sequential imaging should be performed. What is Known:• CNS infections in neonates lead to high mortality and morbidity.• Ventriculitis is a severe complication of meningitis. What is New:• High morbidity; the majority of ventriculitis patients have pre-existing PHVD and develop seizures and hydrocephalus.• Interrater agreement is good; bedside CUS is a useful tool for reaching a sustainable diagnosis of ventriculitis.